What Could Cannabinoids Do for Cancer Patients Beyond Nausea Relief? | Research

The takeaway

A review documented dronabinol's proven uses for chemotherapy nausea and AIDS wasting while identifying potential applications in cancer pain, antitumor effects, mood elevation, muscle relaxation, and insomnia relief.

Read this if you are a cancer patient or caregiver considering cannabinoids for symptom management.

Two proven uses (nausea, appetite) plus potential for pain, mood, sleep in oncology

What the researchers found

Two uses for the synthetic cannabinoid dronabinol were established: chemotherapy-induced nausea and vomiting, and AIDS-related anorexia. Beyond these, the review identified several potential applications relevant to cancer patients: pain relief, antitumor effects (through cannabinoid receptors in immune and neural tissue), mood elevation, muscle relaxation, and insomnia relief.

Two cannabinoid receptor types had been identified: CB1 (mainly central and peripheral nervous system) and CB2 (mainly immune cells). The discovery of both receptors and endocannabinoids had opened new research avenues for pharmaceutical applications.

Why it matters

This review helped frame cannabinoid therapeutics in the oncology context, where patients often deal with multiple symptoms simultaneously. The argument that cannabinoids could address several cancer-related symptoms (nausea, pain, appetite, mood, sleep) with a single class of medications was appealing for patients dealing with polypharmacy.

The numbers in context

No specific quantitative data were presented in the abstract.

How the study worked

This was a narrative review published in Supportive Care in Cancer evaluating established and potential therapeutic applications of cannabinoids specifically for oncology patients.

What this study cannot tell us

The review was primarily descriptive without systematic evidence assessment. Many of the "potential" applications lacked clinical trial support. The distinction between established and speculative applications could have been more clearly delineated.

How to read the evidence

This is a narrative review in a supportive care journal providing moderate-level evidence through synthesis of established and emerging applications.

When this study was published

Published in 2003. Cannabis use among cancer patients has increased substantially since this review.

The bigger picture

Cannabis is now widely used by cancer patients, often alongside conventional treatments. While dronabinol and nabilone remain approved for chemotherapy nausea, many patients prefer plant-based cannabis products. The antitumor potential mentioned here continues to be investigated but has not yielded approved treatments.

Questions still open

Which of the potential applications identified have progressed to clinical trials? How do cannabis-based approaches compare to the newer antiemetics that have largely replaced cannabinoids as first-line treatments for chemotherapy nausea?

Common questions

Can cannabis help with cancer treatment side effects?

Dronabinol (synthetic THC) is approved for chemotherapy-induced nausea and appetite loss in AIDS. This review suggested additional potential benefits for cancer patients including pain relief, mood improvement, and better sleep.

Can cannabis fight cancer itself?

This review mentioned potential antitumor effects, but these have primarily been seen in laboratory studies. No cannabinoid has been approved as a cancer treatment, and the antitumor evidence remains preliminary.

Read the original research

Established and potential therapeutic applications of cannabinoids in oncology.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 11(3), 137-43

View on PubMed ↗

Citation

Walsh, Declan; Nelson, Kristine A; Mahmoud, Fade Aziz. (2003). Established and potential therapeutic applications of cannabinoids in oncology.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 11(3), 137-43.